Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
Status:
Completed
Trial end date:
2018-06-21
Target enrollment:
Participant gender:
Summary
The investigators aimed to confirm the utility of the synergy test results (E-tesT) in vitro
to predict the efficacy and safety of colistin-rifampin combination and colistin monotherapy
in extensively drug-resistant acinetobacter baumannii.